 | • レポートコード：MRC2203A065 • 出版社/出版日：Mordor Intelligence / 2022年1月 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site Licence | ￥962,000 (USD6,500) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社は、世界の熱傷用軟膏市場規模が2020年831.59百万ドルから2026年1176.71百万ドルに達し、2021年から2026年まで年平均5.95％成長すると予測しています。本市場調査レポートでは、熱傷用軟膏の世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品種類別（局所抗生物質、銀、ヨウ素）分析、熱傷深度別（軽度熱傷、部分層熱傷、全層熱傷）分析、エンドユーザー別（病院・クリニック、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）分析、競争状況、市場機会・将来傾向、新型コロナウイルス感染症による市場への影響など、以下の構成でまとめました。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の熱傷用軟膏市場規模：製品種類別（局所抗生物質、銀、ヨウ素） ・世界の熱傷用軟膏市場規模：熱傷深度別（軽度熱傷、部分層熱傷、全層熱傷） ・世界の熱傷用軟膏市場規模：エンドユーザー別（病院・クリニック、その他） ・世界の熱傷用軟膏市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（3M、Cardinal Health、Cipla Limited、…） ・市場機会・将来傾向 ・新型コロナウイルス感染症による市場への影響 |
The burn ointment market was valued at USD 831.59 million in 2020, and it is expected to reach USD 1176.71 million by 2026, registering a CAGR of 5.95% during the forecast period, 2021-2026.
The current COVID-19 outbreak has negatively affected the growth of the market. The outbreak has led to a decline in the number of patients seeking medical help for burns. In addition, the industry players have also reduced their overall expenditure on the research and development of new products in this market. The supply chain has also been disrupted, as various countries are only allowing the import and export of essential medications. It is expected that market players, in order to resume their growth in the market, will come up with a new solution to address the current scenario.
The major factors driving the growth of the market include rising incidences of burn and increasing awareness regarding treatment options. According to the data published by the World Health Organization (WHO) in 2018, globally, on average, 265,000 deaths are caused by burns every year. The majority of these deaths occur in low- to middle-income countries, and half of them occur in Southeast Asia.
Furthermore, the increasing awareness among people regarding various treatment options related to burns is also a key factor driving the market over the forecast period. Owing to the increased awareness, the overall healthcare expenditure on burn care is also increasing. The market is also growing due to the increasing willingness among people to spend more and opt for new advanced blaze wound care products, especially in the case of patients affected with burns. Apart from this, public and private organizations are also running training and awareness programs to further advance the treatment options. For instance, in September 2019, Integra LifeSciences Corporation, in collaboration with the European Burn Association, initiated a training program. The training program was organized for surgeons to inculcate the best practices and training for the treatment of burns. The aim of the training program was to provide adequate knowledge to surgeons regarding the benefit of advanced burn care and increase patient compliance during the treatment.
Thus, the above-mentioned factors are expected to drive the market growth over the forecast period. However, the side effects associated with burnt ointments, such as skin necrosis, itchy skin, redness, etc., are expected to be the major restraining factor for the market.
Key Market Trends
The Topical Antibiotics Segment is Expected to Hold a Significant Market Share Over the Forecast Period
In terms of product type, the market is segmented into topical antibiotics, silver, and iodine. The topical antibiotics segment is expected to hold a significant market share during the forecast period. The major factors propelling the growth of this segment include the high acceptance of burn ointment products in home-care settings and the rising incidence of burns across the globe. Mafenide acetate, Bacitracin, Mupirocin, Neosporin, Polymyxin B, Nitrofurazone, and Nystatin are the widely accepted topical antibiotics burn ointments. As per the Royal Australian College of General Practitioners 2017 report, stated burn injuries are common and costly. Each year, there are more than 200,000 cases, costing the Australian community USD 150 million. The management of initial burns with an ointment is usually considered effective and is preferred even with dressing or other treatments. Thus, the above-mentioned factors are expected to drive the market growth over the forecast period.
The North American Region is Expected to Hold a Major Market Share Over the Forecast Period
In the North American region, the United States is expected to hold a major market share due to well-established healthcare infrastructure and the rising incidence of burns. For instance, as per the American Burn Association 2018 report, in the United States, over 300 children are seen in emergency rooms each day, and about two children die from burn injuries. Children aged 16 years and below represent approximately 26% of all admissions to burn center hospitals in the United States. Also, according to the report published by the National Center for Biotechnology Information (NCBI), approximately 486,000 people suffer from blaze wounds every year. A high incidence of burns is likely to drive the demand for burn ointments. In addition, the presence of key players in this region that are focusing on planned initiatives like the launch of new products and mergers and acquisitions is helping the market grow. Thus, owing to the above-mentioned factors, the burn ointment market in the United States is expected to be one of the largest markets and grow in the future.
Asia-Pacific also presents lucrative opportunities in the current scenario for the key players operating in the burn ointment market due to increased patient awareness toward burn care treatment and management, increase in the number of hospitals, development of the R&D sector, rise in healthcare reforms, and increase in the target population in emerging economies.
Competitive Landscape
The burn ointment market is moderately competitive. The market players are committed to developing innovative healing solutions for customers and patients across the care continuum, generating proven clinical outcomes. The companies are also showing continuous growth and are developing new and differentiated products, which address the evolving healthcare needs among patients. Some of the market players include Johnson & Johnson, Mankind Pharma, Pfizer Inc., Dr.Morepen, Smith & Nephew PLC, and others.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Incidences of Burn
4.2.2 Increasing Awareness Regarding Treatment Options
4.3 Market Restraints
4.3.1 Side Effects Associated with Burn Ointment
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Topical Antibiotics
5.1.2 Silver
5.1.3 Iodine
5.2 By Depth of Burn
5.2.1 Minor Burns
5.2.2 Partial Thickness Burns
5.2.3 Full Thickness Burns
5.3 By End User
5.3.1 Hospitals and Clinics
5.3.2 Other End Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 3M
6.1.2 Cardinal Health
6.1.3 Cipla Limited
6.1.4 ConvaTec Group PLC
6.1.5 DeRoyal Industries Inc.
6.1.6 Dr.Morepen
6.1.7 GlaxoSmithKline PLC
6.1.8 Intergra LifeSciences
6.1.9 Johnson & Johnson
6.1.10 Mankind Pharma
6.1.11 Perrigo Company PLC
6.1.12 Pfizer Inc.
6.1.13 Smith & Nephew PLC
6.1.14 Sun Pharmaceutical Industries Ltd (Ranbaxy Laboratories Limited)
6.1.15 Trio Lifescience Pvt. Ltd
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
8 IMPACT OF COVID-19 ON THE MARKET